Inventor
CASTAN CATHERINE
FR15 patents
⚠️ This page may combine multiple inventors who share the name “CASTAN CATHERINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FLAMEL TECH SA
5 patentsUS7906145B2Mar 15, 2011
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FLAMEL TECH SA101 citations97
US7879362B2Feb 1, 2011
Oral pharmaceutical compositions with controlled release and prolonged absorption
FLAMEL TECH SA51 citations93
US5780579AJul 14, 1998
Method for the preparation of polyamino acids
FLAMEL TECH SA35 citations89
US7910133B2Mar 22, 2011
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
FLAMEL TECH SA8 citations84
US5914098AJun 22, 1999
Aerosol composition for forming a hydrated membrane, and applications thereof
FLAMEL TECH SA1 citations52
CASTAN CATHERINE
4 patentsUS8734850B2May 27, 2014
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
CASTAN CATHERINE39 citations93
US10004693B2Jun 26, 2018
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
CASTAN CATHERINE36 citations92
US9561179B2Feb 7, 2017
Controlled-release floating pharmaceutical compositions
CASTAN CATHERINE39 citations90
US8197850B2Jun 12, 2012
Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
CASTAN CATHERINE9 citations83
FLAMEL IRELAND LTD
3 patentsUSRE47084EOct 16, 2018
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
FLAMEL IRELAND LTD36 citations94
US10092511B2Oct 9, 2018
Controlled-release floating pharmaceutical compositions
FLAMEL IRELAND LTD43 citations94
US9814684B2Nov 14, 2017
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FLAMEL IRELAND LTD36 citations92
GUIMBERTEAU FLORENCE
2 patentsUS8652523B2Feb 18, 2014
Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility
GUIMBERTEAU FLORENCE42 citations93
US8821935B2Sep 2, 2014
Microcapsules with modified release of active principles with low solubility for oral delivery
GUIMBERTEAU FLORENCE42 citations90